Pyxis Oncology, Inc.
- PYXS
- NASDAQ
- Biotechnology
- Oncology Biopharma
- Immuno-Oncology
- Preclinical Cancer Drugs
$1.69
Today +0.60%Quote Oct 19, 2026, 02:00 PM UTC
−50.73%over the last month
Max drawdown −50.7%From 1-month high −50.7%3 months −25.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$141.0M
Quote Oct 19
Next earnings
Nov 2
Expected, not confirmed
Analyst target
$7.67
+353.8% from here
Floor
$1.63
3.4% below price
Where the price sits
12 analysts
Analyst range, low to high
$7.00$8.00
- Price $1.69
- Resistance $1.70
- Consensus $7.67
The price is right under resistance. Analysts' average target sits about 354% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PYXSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
56
Founded
2018